Roche to warn a patent infringement against local companies.

Published: 2005-09-22 06:55:00

Updated: 2005-09-22 06:55:00

F. Hoffmann La Roche AG advised for local companies not to infringe their patent of Carvetidil that was already registered in Korea, an exclusive therapeutic drug for congestive heart failure (CHF), asking them immediately to suspend their production, sales and marketing activities on the carveti...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK